[HTML][HTML] Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis

EG Harper, C Guo, H Rizzo, JV Lillis, SE Kurtz… - Journal of Investigative …, 2009 - Elsevier
EG Harper, C Guo, H Rizzo, JV Lillis, SE Kurtz, I Skorcheva, D Purdy, E Fitch, M Iordanov
Journal of Investigative Dermatology, 2009Elsevier
T helper (Th) 17 cells have recently been implicated in psoriasis pathogenesis, but
mechanisms of how these cells traffic into inflamed skin are unknown. By immunostaining for
interleukin (IL)-17A and IL-22, we show numerous cells present in psoriasis lesions that
produce these cytokines. We next found that Th17 cytokines (IL-17A, IL-22, and tumor
necrosis factor (TNF)-α) markedly increased the expression of CC chemokine ligand (CCL)
20, a CC chemokine receptor (CCR) 6 ligand, in human keratinocyte monolayer and raft …
T helper (Th) 17 cells have recently been implicated in psoriasis pathogenesis, but mechanisms of how these cells traffic into inflamed skin are unknown. By immunostaining for interleukin (IL)-17A and IL-22, we show numerous cells present in psoriasis lesions that produce these cytokines. We next found that Th17 cytokines (IL-17A, IL-22, and tumor necrosis factor (TNF)-α) markedly increased the expression of CC chemokine ligand (CCL) 20, a CC chemokine receptor (CCR)6 ligand, in human keratinocyte monolayer and raft cultures in a dose- and time-dependent manner. Lastly, we showed in mice that subcutaneous injection with recombinant IL-17A, IL-22, or TNF-α led to the upregulation of both CCL20 and CCR6 expression in skin as well as cutaneous T-cell infiltration. Taken together, these data show that Th17 cytokines stimulate CCL20 production in vitro and in vivo, and thus provide a potential explanation of how CCR6-positive Th17 cells maintain their continual presence in psoriasis through a positive chemotactic feedback loop.
Elsevier